Skip to main content
Clinical Trials/NCT01219595
NCT01219595CompletedNot Applicable

Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women

University of Wisconsin, Madison2 sites in 1 country65 target enrollmentStarted: September 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
65
Locations
2
Primary Endpoint
Pre-treatment heterogeneity or prevalence

Study Overview

Brief Summary

The purpose of the research is to determine if eating sweetened, dried cranberries or strawberry fruit pieces will increase the types of different E. coli bacteria in the intestines which may reduce the likelihood of a major, or highly harmful urinary type of bacteria which cause urinary tract infections in susceptible women.

Detailed Description

This is a research study about the number and types of bacteria that cause urinary tract infections (E. coli strains) that are present in the intestine. The bacteria will be collected and analyzed before and after eating either sweetened, dried cranberries or strawberry fruit pieces. This study will help us learn more about whether or not the components of consumed sweetened, dried cranberries or strawberry fruit pieces reduce the numbers of harmful E. coli bacteria in the vaginal and intestinal tracts, thereby reducing the number of urinary tract infections among women.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Women, ages 18-65
  • History of recurrent urinary tract infections defined as three in the past year, or two in the last six months
  • Subjects must be willing to follow the study protocol that includes consuming the mandatory daily dose of cranberries or strawberry fruit pieces and traveling to the UWHC Urology clinic for scheduled rectal and vaginal swab procedures.
  • The non-UTI-susceptible group will include women ages 18-65 with no history of recurrent UTI's as defined above.

Exclusion Criteria

  • Are pregnant
  • Have an immune compromising disease
  • Have diabetes
  • Have kidney stones
  • Have chronic bowel inflammatory disease
  • Have known allergies to cranberries, strawberries, elderberries, or wheat fiber
  • Non-UTI-susceptible group will include women ages 18-65 with no history of recurrent UTI's as defined above.

Outcomes

Primary Outcomes

Pre-treatment heterogeneity or prevalence

Time Frame: Day 1 - prior to start of study treatment

1\) Prevalence or heterogeneity of E. coli strains in UTI susceptible women pre-treatment

Maintenance of heterogeneity in the intestinal flora

Time Frame: Approximately 3 months

To determine whether a shift towards strain heterogeneity in the intestinal flora can be maintained over a three month period.

Measure Effects of sweetened, dried cranberries on E. coli clonotypes over three two-week exposures

Time Frame: Approximately 3 months

Measure effects of sweetened, dried cranberries on E. coli clonotypes over three two-week exposures

Measure effects of sweetened, dried cranberries on E. coli clonotypes over one 4-week exposure

Time Frame: 2 weeks, 1 month, or 3 months

Measure effects of sweetened, dried cranberries on E. coli clonotypes over one 4-week exposure

Measure the UTI recurrence

Time Frame: 2 weeks, 1 month, or 3 months

Measure the UTI recurrence after 6 months from the beginning of the study.

Comparison of sweetened dried cranberries to a placebo group

Time Frame: 2 weeks, 1 month, or 3 months

Comparison of sweetened dried cranberries to a placebo group (strawberry fruit pieces)

Post-treatment heterogeneity

Time Frame: 2 weeks, 1 month, or 3 months

2\) a change in the heterogeneity of strains post treatment

Patient acceptance of study regimen

Time Frame: 2 weeks, 1 month, or 3 months

3\) patient acceptance of the study regimen

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials